Myeloproliferative disorders can strike at any age, and they have no known cause. Symptoms, prognosis and progression can vary. Some patients may have slowly progressing disease that may not require any treatment beyond careful monitoring while others may progress to more advanced stages, including in some cases, AML, acute myelogenous leukemia. Learn from experts more about myeloproliferative disorders, how they are treated and the advances being made through research and clinical trials.